BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 12, 2001
View Archived Issues
NIH licensing opportunity: ribonuclease H1
Read More
Avant Immunotherapeutics updates development programs
Read More
Neurocrine announces encouraging phase I data for CRF1 antagonist
Read More
Regulation of Cyr61 gene expression and cell migration or chemotaxis
Read More
Inhibitex initiates phase II trial of therapy for life-threatening staphylococcal infections
Read More
Protegrin IB-367 shows antimicrobial activity, good safety in phase IIa for prevention of VAP
Read More
TranXenoGen and Abbott establish collaboration for monoclonal antibody production
Read More
Genmab reports encouraging results with HuMax-CD4 for RA
Read More
ACE inhibitor lisinopril effective in prophylactic therapy of migraine
Read More
NCX-4016 reduces restenosis in hypercholesterolemic mice
Read More
Treatments for Huntington's disease and related disorders sought by Cogent and Elan
Read More
Protarga begins phase II trial of Taxoprexin DHA-paclitaxel
Read More
Ezetimibe can be safely administered to adolescents and in combination with a number of drugs
Read More
Trials begin with human protein for the prevention of chronic lung disease in premature babies
Read More
Analogues of BD-1008 possess functional sigma receptor antagonism and anticocaine effects
Read More
Targacept and Dr. Falk to develop novel ulcerative colitis therapy
Read More
Texas Biotechnology summarizes major achievements over past year
Read More
Proof-of-principle clinical study begins for P-57 as obesity treatment
Read More
Bilobalide-derived NV-31 appears to promote neuronal survival via antioxidant effect
Read More
YC-1 may prevent development of tolerance to organic nitrate therapy
Read More
Recombinant human C1 inhibitor enters trials for hereditary angioedema
Read More
Methods of treating and diagnosing lysosomal storage diseases
Read More
New series of bradykinin receptor antagonists designed by Pharmacopeia
Read More
Pseudomycin-related antifungal agents under study at Lilly
Read More
Recent patent describes metabolite of MDL-100907 and its use in schizophrenia, anxiety, etc.
Read More
Heterobicyclic inhibitors of factor Xa synthesized at DuPont as potential new anticoagulants
Read More
Analgesic compounds claimed in international patent by Gruenenthal
Read More
Fujisawa claims cGMP-PDE inhibitors particularly useful for erectile dysfunction Rx
Read More